Signalling processes in endothelial ageing in relation to chronic oxidative stress and their potential therapeutic implications in humans by van der Loo, B et al.
University of Zurich
Zurich Open Repository and Archive
Winterthurerstr. 190
CH-8057 Zurich
http://www.zora.uzh.ch
Year: 2009
Signalling processes in endothelial ageing in relation to chronic
oxidative stress and their potential therapeutic implications in
humans
van der Loo, Bernd; Schildknecht, Stefan; Zee, Rebecca; Bachschmid, Markus M
van der Loo, Bernd; Schildknecht, Stefan; Zee, Rebecca; Bachschmid, Markus M (2009). Signalling processes in
endothelial ageing in relation to chronic oxidative stress and their potential therapeutic implications in humans.
Experimental Physiology, 94(3):305-310.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
Experimental Physiology 2009, 94(3):305-310.
van der Loo, Bernd; Schildknecht, Stefan; Zee, Rebecca; Bachschmid, Markus M (2009). Signalling processes in
endothelial ageing in relation to chronic oxidative stress and their potential therapeutic implications in humans.
Experimental Physiology, 94(3):305-310.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
Experimental Physiology 2009, 94(3):305-310.
Signalling processes in endothelial ageing in relation to chronic
oxidative stress and their potential therapeutic implications in
humans
Abstract
Ageing is an important risk factor for the development of cardiovascular diseases. Vascular ageing is
mainly characterized by endothelial dysfunction, an alteration of endothelium-dependent signalling
processes and vascular remodelling. The underlying mechanisms comprise increased production of
reactive oxygen species (ROS), inactivation of nitric oxide (.NO) and subsequent formation of
peroxynitrite (ONOO(-)). Elevated ONOO(-) may exhibit new messenger functions by post-translational
oxidative modification of intracellular regulatory proteins. Mitochondria are a major source of
age-associated superoxide formation, as electrons are misdirected from the respiratory chain.
Manganese superoxide dismutase (MnSOD), a mitochondrial antioxidant enzyme, is an integral part of
the nucleoids and may protect mitochondrial DNA from ROS. A model linking .NO, mitochondria,
MnSOD and its acetylation/deacetylation by sirtuins (NAD+-dependent class III histone deacetylases)
may be the basis for a potentially new powerful therapeutic intervention in the ageing process.
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Abstract 
 
Aging is an important risk factor for the development of cardiovascular 
diseases. Vascular aging is mainly characterized by endothelial dysfunction, an 
alteration of endothelium-dependent signalling processes and vascular remodelling. 
The underlying mechanisms comprise increased production of reactive oxygen 
species (ROS), inactivation of nitric oxide (NO), and subsequent formation of 
peroxynitrite (ONOO–). Elevated ONOO– may exhibit new messenger functions by 
posttranslational oxidative modification of intracellular regulatory proteins.  
Mitochondria are a major source of age-associated superoxide (O2–) 
formation, as electrons are misdirected from the respiratory chain. Manganese 
superoxide dismutase (MnSOD), a mitochondrial antioxidant enzyme, is an integral 
part of the nucleoids and may protect mitochondrial DNA (mtDNA) from ROS. A 
model linking NO, mitochondria, MnSOD and its acetylation/deacetylation by sirtuins 
(NAD+-dependent class III histone deacetylases) may be the basis for a potentially 
new powerful therapeutic intervention in the aging process. 
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Introduction 
 
Cardiovascular diseases have a higher incidence with increasing age, even in 
the absence of established risk factors. This suggests that aging per se alters 
vascular function. Vascular aging is mainly characterized by endothelial dysfunction 
(van der Loo et al. 2000), associated with decreased endothelium-dependent 
relaxations with increasing age (Tschudi et al. 1996). The endothelium exerts a 
multimodal regulation of vascular tone, structure and function by the release of 
vasoactive substances, which, under physiological conditions, are finely balanced to 
ensure vascular homeostasis. However, with increasing age, this equilibrium cannot 
be preserved any longer. An age-associated enhanced O2– production in the 
vasculature (Oudot et al., 2006, van der Loo et al., 2000), mainly derived from the 
endothelium, occurs and is the basis for the “oxidative-stress theory” of vascular 
aging. It is obvious that ROS play a pivotal role in endothelial cell redox signalling. 
Knowledge about their sources, the signalling cascades they modify, as well as the 
compensatory mechanisms will enhance our knowledge of the vascular aging 
process. The particular understanding about how redox systems are regulated in the 
elderly may also help to identify new targets to treat aging, which is, besides 
smoking, diabetes, hypertension and obesity, a major cardiovascular risk factor. 
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Endothelial Dysfunction versus Endothelial Cell Activation 
 
The endothelium controls homeostatic conditions by the release of potent 
endothelium-derived autacoids. Endothelial cell properties and the signalling 
processes are altered in a variety of pathophysiological conditions such as 
inflammation, exogenous noxes and aging. For the description of endothelial 
alterations several terms and definitions have been used such as endothelial 
dysfunction and endothelial cell activation (Cines et al. 1998). The latter is based on 
the fact that the endothelium is an integral part of the innate immune system, 
controlling adhesion and transcytosis of leukocytes and monocytes to the site of 
inflammation. Locally invading pathogens can trigger the release of cytokines by 
tissue macrophages, thus activating the endothelium and guiding immune cells to the 
site of inflammation. This involves the opening of the endothelial cell barrier, 
reduction of the release of repellent molecules, expression of adhesion molecules 
and finally the controlled diapedesis of immune cells. This process is a fully reversible 
physiological reaction to inflammation or injury, but chronic exposure to ROS, as in 
the aging process, may lead to irreversible changes and damage of the endothelial 
cell layer. 
At the molecular level two subsequent strictly timed phases can be 
distinguished and are called endothelial cell activation type I and II. The first phase 
(ECA type I), in which endothelial cells retract from each other, express P-selectin 
(Prescott et al. 2001) and release the von Willebrand factor, is entirely independent of 
de novo protein synthesis and essentially completed within 1 h. We suggested an 
inhibition of NO and prostaglandin I2 (PGI2) production by a novel mechanism 
involving ONOO– formation from NO and a still unknown source of O2– radicals 
(Ullrich and Bachschmid, 2000). ONOO– then causes tyrosine nitration and 
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concomitant inhibition of prostaglandin synthase (PGIS) (Ullrich and Bachschmid, 
2000). This leads to accumulation of PGH2, which is able to activate the TxA2/PGH2 
receptor both mediating smooth muscle contraction and activation of platelets and 
white cells. 
A second stage (ECA type II) becomes apparent after 1h and involves 
induction and expression of early genes like the adhesion molecules ICAM or VCAM, 
proinflammatory cytokines as well as regulatory enzymes such as NOS-2 and COX-
2. As a consequence white cells can tightly adhere and migrate into tissues, NO and 
prostaglandins are formed in excess and cytokines orchestrate the inflammatory 
response. 
It is crucial to understand the molecular mechanisms behind endothelial cell 
activation in order to develop pharmacological strategies to prevent this process or, 
more importantly, to induce resolution and reversal of inflammation.  
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Free radicals and vascular aging 
 
NO is one of the most important mediators of the cardiovascular system and 
has been extensively studied in the past. Pathophysiologically, endothelial 
dysfunction is described as a paradoxical response of the vasculature to 
acetylcholine, reacting with constriction instead of relaxation. Normally, acetylcholine 
triggers the specific endothelium-derived release of NO leading to vascular 
relaxation. Studies on aging in animal models and humans have proven that the 
bioavailability of NO is continuously diminished and, in parallel, endothelium-derived 
superoxide (O2–) increases (van der Loo et al. 2000; Krause, 2007).  
O2– is a highly efficient scavenger for NO causing formation of the very 
reactive and deleterious ONOO– in a near diffusion-controlled reaction (Beckman and 
Koppenol, 1996). At high concentrations (micromolar range) peroxynitrite oxidizes 
unspecifically any biological macromolecule such as DNA, proteins and lipids. At 
lower concentrations (nanomolar) it interferes with important vascular signalling 
pathways such as NO and prostaglandin signalling, calcium homeostasis, MAP 
kinase cascade, NFB and AP-1 (Xie et al. 2006). Thus an increase in O2– and 
subsequent peroxynitrite formation reduces the bioavailability of NO and leads to 
endothelial dysfunction, one of the major causes for the progression of vascular 
disease and senescence.  
 When studying the distribution of 3-nitrotyrosine residues, a typical end 
product of the reaction of ONOO– with biological compounds, by using immunogold 
labelling and electron microscopy, we found the most significant accumulation of 
nitrotyrosine in the mitochondria, suggesting primarily a mitochondrial source of O2– 
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(van der Loo et al. 2000). However, other potential sources of O2– production, such 
as subunits of the NADPH oxidase (Krause, 2007), xanthine oxidase, and an 
uncoupled eNOS (NOS III) have to be considered. Both upregulation of eNOS (van 
der Loo et al. 2000) and reduced levels of enzyme expression (Cernadas et al. 1998) 
have been observed with increasing age. Our own data demonstrating a steep 
increase both in expression and in activity of eNOS support the concept that eNOS 
may, as an oxidase, become part of a redox system increasing electron transfer to 
molecular oxygen.   
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The role of mitochondria 
 
 Under physiological conditions, approximately 0.1% of O2– consumed by 
mitochondria is reduced to O2– (Fridovich, 2004). 
Age-associated mitochondrial dysfunction implies increased generation of  
O2– and peroxynitrite by misdirection of electrons from the respiratory chain into 
ROS production due to a decline of mitochondrial function (van der Loo et al. 2000), 
such as inactivation of aconitase, reduced ATP synthesis and enhanced permeability 
transition pore opening leading to apoptosis. This initiates a “vicious cycle” of 
increased (nuclear and mitochondrial) DNA damage leading again to more ROS 
generation entailing further mitochondrial DNA (mtDNA) damage (Finkel and 
Holbrook, 2000) (figure 1). MtDNA is considered to be far more susceptible to 
oxidative stress than nuclear DNA because  
(a) of the proximity of mtDNA to the source of free oxygen radicals,  
(b) protective mitochondrial histone proteins are absent (Larsen et al. 2005), 
and  
(c) mitochondria lack efficient DNA repair mechanisms (Larsen et al. 2005).  
Interestingly, experimental evidence in C. elegans has also been provided for a direct 
link between mitochondrial ROS generation and nuclear (genomic) DNA damage 
(Hartman et al. 2004). However, the exact signalling pathways determining the 
molecular basis for the link between life-long damage to mtDNA and age-associated 
vascular dysfunction are not yet fully understood to date.  
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Antioxidant systems and compensatory mechanisms 
 
 Based upon the oxidative stress hypothesis of vascular aging, naturally 
occurring antioxidants such as vitamins would seem to be attractive candidates to 
prevent ROS production. Vitamin E is an important electron source for the reduction 
of ONOO– (Lee et al. 1998). However, in aged rats fed a normal diet and not 
susceptible to atherosclerosis, -tocopherol, the biologically most active form of 
vitamin E, was found to be markedly increased in both plasma and major organs. The 
highest, up to 70-fold, increase was found in the aortic wall (van der Loo et al. 2002). 
This suggests that sufficiently high levels of antioxidant vitamin E may be built up 
from a normal diet in an attempt to counterbalance age-associated oxidative stress 
and that this may represent a self-regulatory protective adaptation. 
Under physiological conditions antioxidant enzymes prevent the detrimental 
effects of O2–. Apart from mitochondrial MnSOD (Sod 2), EC-SOD (Sod 3) is the 
main scavenger of O2– in the extracellular space and Cu,ZnSOD (Sod 1) in the 
cytosol, respectively. Cu,ZnSOD was recently shown to lose its membrane and 
caveolae association and to relocate to the mitochondria in an age-dependent 
manner (van der Loo et al. 2006). Unlike MnSOD, constitutively expressed in 
mitochondria, Cu,ZnSOD is not inactivated by ONOO– -mediated tyrosine nitration as 
a function of age. The process may be regulated by age-dependent elevated O2– 
levels of copper chaperone for superoxide dismutase in the intermembrane space 
resulting in retention of Cu,ZnSOD in the mitochondria. Thus, the enzyme becomes 
part of a compensatory defense against compromised mitochondrial function. 
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Sirtuins in vascular aging 
 
Sirtuins (SIRT, silent information regulator two) are a class of NAD+-dependent 
protein deacetylases and are known to be able to increase lifespan by mechanisms 
similar to calorie restriction (Bordone and Guarente, 2005). These mechanisms 
include most importantly the control of glucose metabolism in hepatocytes by 
modulation (deacetylation) of PGC-1 (PPAR (peroxisome proliferator-activated 
receptor)  coactivator 1) (Rodgers et al. 2005) and suppression of PPAR -controlled 
genes involved in the regulation of fat tissue (Picard et al. 2004). At least seven 
isoforms exerting diverse functions exist in humans. SIRT1, by far the best 
investigated of the homologues so far, deacetylates p53, a well known transcription 
factor promoting senescence, thereby limiting premature cellular senescence 
(Langley et al. 2002).  Resveratrol is one of the polyphenols found in red wine and 
responsible for cardiovascular protective effects (Opie and Lecour, 2007). 
Resveratrol has been shown to be able to activate SIRT1 (but not other sirtuin 
homologues) by promoting a conformational change in the enzyme (Borra et al. 
2005). Resveratrol can extend lifespan in yeast and in mice on a high-calorie diet 
(Baur et al. 2006), indicating a potentially new powerful intervention in the aging 
process. Treatment of mice with resveratrol leads to an increase in mitochondrial 
size, enzymatic activity, mitochondrial DNA (mtDNA) content and enrichment of 
genes involved in mitochondrial biogenesis in skeletal muscle (Lagouge et al. 2006). 
These effects on mitochondrial function are mediated by SIRT1 and PGC-1with 
Sirt1 deacetylating and hereby activating PGC-1(Lagouge et al. 2006). A recent 
study in mice on a high-fat diet moderately over-expressing SIRT1 proved that SIRT1 
can lower lipid-induced inflammation along with an improved glucose tolerance. In 
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part these effects are mediated by down-modulation of NFkB resulting in reduced 
activation of proinflammatory cytokines such as TNF and IL-6 and an increased 
expression of MnSOD (Pfluger et al. 2007). The effects of a natural compound on life 
span will certainly lead to the development of more potent analogs of resveratrol for 
in vivo use in the future (Koo and Montminy, 2006). 
Interestingly, calorie restriction was also recently shown to induce eNOS 
expression in various mouse tissues, accompanied by a promotion of mitochondrial 
biogenesis, increased mtDNA content and SIRT1 expression, dependent on eNOS-
derived NO (Nisoli et al. 2005). Furthermore, in a model of stress-induced (treatment 
of human umbilical vein endothelial cells with hydrogen peroxide) premature 
senescence (SIPS), the selective PDE3 inhibitor cilostazol reduced the senescent 
cell phenotype by upregulation of SIRT1 (Ota et al. 2008).  These findings may lead 
to a recently proposed model linking calorie restriction, NO, SIRT1, and activation of 
mitochondria (Guarente, 2005).  
Therefore, the development of SIRT1 activators may potentially be highly 
beneficial for the aged cardiovascular system in order to restore endothelial function 
by activating eNOS and by reducing mitochondrial O2– formation via induction of 
MnSOD expression. 
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A mechanistic concept of age-associated mitochondrial dysfunction 
 
 Mitochondrial proofreading-deficient polymerase  (Pol) knock-in mice have 
been shown to accumulate mtDNA mutations and deletions, resulting in premature 
aging (Trifunovic et al. 2004; Kujoth et al. 2005). Protective mechanisms must exist 
within the nucleoids to shield mtDNA from ROS produced by the nearby electron 
transport chain. MnSOD, an antioxidant enzyme localized in the mitochondria, has 
been demonstrated to be an integral component of the nucleoids where it can protect 
mtDNA from ROS (J. Kienhoefer and M. Bachschmid, unpublished data). MnSOD 
can be acetylated which may modulate its association to mtDNA (Kim et al. 2006) in 
analogy to the control of nuclear chromatin plasticity by histone acetylation/ 
deacetylation. 
 Mitochondria harbour three sirtuin isoforms which, by deacetylation, may 
increase the association of MnSOD and other protective proteins with mtDNA and 
may regulate replication and transcription of mtDNA by modulating the composition 
and density of the nucleoids. Peroxynitrite can inactivate SIRT1, presumably via 
disruption of the zinc finger (Min et al. 2001). This suggests that sirtuins are sensitive 
to ROS and can lose their ability to maintain mtDNA in a more protected form. 
Finally, with an increasing rate of mutations in mtDNA, this will lead to a 
malfunctioning respiratory chain and enhanced ROS generation within mitochondria, 
similar to the effects seen in Pol proofreading-deficient mice exhibiting the features 
of premature aging (Trifunovic et al. 2004; Kujoth et al. 2005) (figure 2).   
 If this concept holds true, the potential therapeutic implications to combat the 
loss of protection of mtDNA against ROS may have an enormous impact.  
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LEGENDS TO FIGURES  
 
Figure 1. Mitochondrial reactive oxygen and nitrogen species formation. The 
mitochondrial respiratory chain continuously shuttles complex I or II-derived electrons 
via ubiquinone, complex III and cytochrome c to complex IV (cytochrome c oxidase). 
The terminal complex IV transfers electrons to molecular oxygen (O2), producing 
water (H2O). Complex I, III and IV use the energy from the electrons to create the 
electrochemical gradient by pumping protons across the inner mitochondrial 
membrane for ATP synthesis at complex V (oxidative phosphorylation). Electron 
leaks at complex I, III and ubiquinone lead to O2– formation, which is sequentially 
detoxified by MnSOD, glutathione peroxidase and mitochondrial peroxiredoxins or 
glutaredoxin. Changes in the mitochondrial GSH/GSSG ratio can cause protein 
glutathiolation, which in the case of complex I results in inhibition. 
Mitochodrial NO may be derived from a mitochondrial NO synthase isoform, from 
nitrite reduction at complex III or diffuses from the outside into the mitochondria. •NO 
combines with mitochondrial O2– to form the highly reactive peroxynitrite which may 
nitrate and inactivate MnSOD, cause mtDNA lesions or diffuse into the cytosol. 
Oxidative mtDNA lesions promote mutation and dysfunction of respiratory chain 
components, thus enhancing free radical formation and mitochondrial dysfunction. In 
order to compensate for an age-dependent increase in mitochondrial superoxide 
formation newly synthesized and unfolded Cu,Zn SOD can translocate into the 
mitochondrial intermembrane space, is then folded and loaded with Zn and Cu in 
order to shield the cytosol from O2–.  
Abbreviations: NO, nitric oxide; ONOO–, peroxynitrite; O2–, superoxide; TOM, 
translocase of the outer membrane; MnSOD, manganese superoxide dismutase; 
GSH; reduced glutathione; GSSG, oxidized glutathione; CCS, copper chaperone for 
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Cu,Zn superoxide dismutase; Q, ubiquinone or coenzyme Q10, IMS, intermembrane 
space. 
 
Figure 2. Cytosolic control of mitochondrial ROS formation and effects of 
sirtuins. Various signaling cascades can affect mitochondrial physiology, mediate 
mitochondrial radical formation or are connected to apoptotic signaling.  Oxidative 
stress activates PKC leading to serine-phosphorylation of p66Shc, which 
subsequently translocates to the mitochondrial intermembrane space and associates 
with the TIM-TOM l protein import complex. Proapoptotic stimuli release p66Shc from 
the complex and via interaction with cytochrome c hydrogen peroxide is formed, 
which triggers the permeability transition pore and initiates apoptosis. Mitochondrial 
translocation has also been reported for p53 and p21Ras. Both molecules are 
assumed to sequester antiapoptotic proteins of the Bcl-family, thus promoting free 
radical formation and apoptosis. Furthermore, the stability of p53 is regulated by 
lysine-acetylation, which competes with ubiquitinylation and subsequent proteasomal 
degradation. ROS may inactivate SIRT1 by oxidation of an essential structural Zn-
finger that may result in p53 accumulation and mitochondrial translocation. Another 
example is TNF-signaling involving the ceramide pathway that increases 
mitochondrial superoxide formation at complex III. Mitochondria also respond very 
sensitively to oxidative stimuli or metabolic cues with enhanced electron leakage and 
free radical formation. This may alter the composition of mitochondrial nucleoids, 
protein-DNA complexes, and increase the mtDNA mutation rate. Similar to 
organization of nuclear DNA, mitochondrial sirtuins may regulate nucleoid plasticity. 
Abbreviations: SIRT, sirtuin, Ac, acetylation; ROS, reactive oxygen species; 
MnSOD, manganese superoxide dismutase; Gpx, glutathione peroxidase; mTFA, 
mitochondrial transcription factor A. 
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